Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved

  • Stefan D Anker*
  • , Javed Butler
  • , Muhammad Shariq Usman
  • , Gerasimos Filippatos
  • , João Pedro Ferreira
  • , Edimar Bocchi
  • , Michael Böhm
  • , Hans Pieter Brunner-La Rocca
  • , Dong-Ju Choi
  • , Vijay Chopra
  • , Eduardo Chuquiure
  • , Nadia Giannetti
  • , Juan Esteban Gomez-Mesa
  • , Stefan Janssens
  • , James L Januzzi
  • , José R González-Juanatey
  • , Bela Merkely
  • , Stephen J Nicholls
  • , Sergio V Perrone
  • , Ileana L Piña
    • Piotr Ponikowski, Michele Senni, David Sim, Jindrich Spinar, Iain Squire, Stefano Taddei, Hiroyuki Tsutsui, Subodh Verma, Dragos Vinereanu, Jian Zhang, Tomoko Iwata, Janet M Schnee, Martina Brueckmann, Stuart J Pocock, Faiez Zannad
*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

INIS

Pharmacology, Toxicology and Pharmaceutical Science